The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial

Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks

(2013) Xin-Min Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Evidence for a role of CETP in HDL remodeling and cholesterol efflux: Role of cysteine 13 of CETP

(2013) Cyrille Maugeais et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects

(2013) Robin P. F. Dullaart et al.   Obesity

Inflammation modulates human HDL composition and function in vivo

(2012) Margarita de la Llera Moya et al.   ATHEROSCLEROSIS

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   CIRCULATION

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?

(2012) Aneta Otocka-Kmiecik et al.   PROGRESS IN LIPID RESEARCH

Metabolic and functional relevance of HDL subspecies

(2011) Bela F Asztalos et al.   CURRENT OPINION IN LIPIDOLOGY

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reconstituted HDL in Acute Coronary Syndromes

(2010) Rémy Chenevard et al.   Cardiovascular Therapeutics

Importance of macrophage cholesterol content on the flux of cholesterol mass

(2010) Sandhya Sankaranarayanan et al.   JOURNAL OF LIPID RESEARCH

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

(2010) Eric J. Niesor et al.   JOURNAL OF LIPID RESEARCH

High-Density Lipoprotein and Coronary Heart Disease

(2010) Pradeep Natarajan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

(2009) Gregory G. Schwartz et al.   AMERICAN HEART JOURNAL

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

(2008) Daniel Bloomfield et al.   AMERICAN HEART JOURNAL

The role of dysfunctional HDL in atherosclerosis

(2008) Mohamad Navab et al.   JOURNAL OF LIPID RESEARCH